Inhibrx INBX

$ 13.95 -0.64%

Annual report 2023
added 02-28-2024

Inhibrx Financial Statements 2011-2024 | INBX

Annual Financial Statements Inhibrx

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.75 B	947 M	1.01 B	848 M	-	-	-	-	-	-	-	-	-
Shares	47.1 M	40.1 M	38 M	25.3 M	-	-	-	-	-	-	-	-	-
Historical Prices	37	23.6	26.6	31.7	-	-	-	-	-	-	-	-	-
Net Income	-241 M	-145 M	-81.8 M	-76.1 M	-51.4 M	-31.2 M	-19.4 M	-	-	-	-	-	-
Revenue	1.8 M	2.19 M	7.23 M	12.9 M	13.2 M	8.6 M	8.39 M	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	12.9 M	-	-	-	-	-	-	-	-	-
Operating Income	-219 M	-129 M	-76.6 M	-67.4 M	-43.7 M	-	-	-	-	-	-	-	-
Interest Expense	-580 K	1 K	14 K	-2 K	-53 K	-	-	-	-	-	-	-	-
EBITDA	-218 M	-128 M	-75.4 M	-66.4 M	-42.6 M	-28.8 M	-19.3 M	-	-	-	-	-	-
Operating Expenses	221 M	131 M	83.8 M	80.3 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	29.4 M	21.1 M	12.4 M	6.84 M	9.02 M	4.65 M	2.61 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Inhibrx

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	47.2 M	43.6 M	43.6 M	43.6 M	39.1 M	39 M	39 M	39 M	37.9 M	37.8 M	37.7 M	37.7 M	26.8 M	18.2 M	18.2 M	18.2 M	18.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-51.8 M	-47.1 M	-48.9 M	-	-35.3 M	-37.7 M	-31.3 M	-	-20.6 M	-20.7 M	-19.3 M	-	-20.5 M	-17.9 M	-20.1 M	-	-20.2 M	-11.1 M	-3.85 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	119 K	30 K	17 K	-	278 K	711 K	929 K	-	2.53 M	954 K	889 K	-	5.9 M	3.34 M	872 K	-	1.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-45.8 M	-41.3 M	-43.8 M	-	-30 M	-34.6 M	-29 M	-	-18.8 M	-19.8 M	-18.6 M	-	-15.6 M	-17.2 M	-17.6 M	-	-13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-135 K	-217 K	-70 K	-	18 K	17 K	37 K	-	-1 K	5 K	16 K	-	-	-5 K	10 K	-	-70 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-45.5 M	-41 M	-43.5 M	-	-29.7 M	-34.3 M	-28.7 M	-	-18.5 M	-19.5 M	-18.3 M	-	-15.3 M	-17 M	-17.4 M	-	-12.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	45.9 M	41.4 M	43.8 M	-	30.3 M	35.3 M	29.9 M	-	21.3 M	20.8 M	19.4 M	-	21.5 M	20.5 M	18.5 M	-	14.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	7.89 M	7.26 M	6.4 M	-	5.35 M	5.4 M	5.05 M	-	2.85 M	2.85 M	3.01 M	-	1.62 M	1.53 M	1.47 M	-	1.48 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency